This inventor holds 47 USPTO granted patents, primarily in Pharmaceutical Compositions. Top assignees: Dr. Karl Thomae Gmbh, Karl Thomae Gmbh, Dr. Karl Thomae Gesellschaft MIT Beschrankter Haftung. Active years: 1982-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Biberach an der Riss, DE (1982)
- Biberach 1, DE (1996)
- Biberbach, DE (1996)
- Biberach DE (1996)
- Biberach, DE (1984 - 1999)
Company Filing History:
26 out of 133 
14 out of 36 
4 out of 21 
Years Active: 1982-1999
Areas of Expertise:
Title: Johannes M Weisenberger: Pioneering Innovations in Carboxylic Acid Derivatives and Medicaments
Introduction:
Johannes M Weisenberger is a renowned inventor and scientist hailing from Biberach, Germany. With an impressive track record of 47 patents, Weisenberger has made substantial contributions to the field of pharmaceuticals, specifically in the development of carboxylic acid derivatives and their applications in medicaments. This article aims to shed light on Weisenberger's latest patents, notable career highlights, collaborations, and the impact of his groundbreaking work.
Latest Patents:
Weisenberger's most recent patents revolve around the discovery of carboxylic acid derivatives and their therapeutic applications. One notable patent involves compounds with the general formula ##STR1## These compounds, along with their tautomers, stereoisomers, and salts, possess valuable pharmacological properties, particularly in the field of aggregation-inhibiting actions. This patent presents innovative solutions to address various medical conditions and offers promising possibilities for drug development.
Career Highlights:
Throughout his illustrious career, Weisenberger has worked with prominent pharmaceutical companies, significantly impacting the industry. Notably, he has collaborated with Dr. Karl Thomae GmbH, a well-established German pharmaceutical company. Weisenberger's association with Dr. Karl Thomae GmbH showcases his expertise and his ability to develop practical solutions that align with industry requirements. Additionally, Weisenberger has also made notable contributions during his tenure at Karl Thomae GmbH.
Collaborations:
Weisenberger's collaborative efforts have brought together notable minds in the pharmaceutical realm. His work with Helmut Pieper and Frank Himmelsbach has been instrumental in advancing the research and development of carboxylic acid derivatives and their applications in medicaments. Together, they have contributed to the creation of impactful intellectual property and expanded the boundaries of pharmaceutical innovation. The collaborations highlight Weisenberger's ability to engage with fellow experts and combine their expertise to achieve groundbreaking results.
Conclusion:
Johannes M Weisenberger stands as a prominent figure in the field of pharmaceutical innovation, with an extensive list of patents and remarkable contributions to carboxylic acid derivatives and the development of medicaments. His latest patents signify his continuous dedication towards making breakthrough discoveries to address significant medical challenges. Weisenberger's collaborations with esteemed scientists reflect his ability to foster fruitful partnerships and drive innovation in the industry. As the pharmaceutical field progresses, Weisenberger's contributions will undoubtedly inspire further advancements and enhance the development of novel treatments and medications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile